Abstracts - 23rd FHNO Conference, 2023
Journal of Head & Neck Physicians and Surgeons · 2024
DOI: 10.4103/2347-8128.243190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Head & Neck Physicians and Surgeons, 2024.
Abstract (Originalsprache)
Basic/Translational Research: Podium/Poster Presentation ABT0017: Clinical Significance of Prosaposin A in Head Neck Cancers: A Pilot Study Sushmita Ghoshal, Avradeep Dutta, Rajandeep Kaur, Arnab Pal Postgraduate Institute of Medical Education and Research, Chandigarh, India E-mail: [email protected] Aims/Objectives: Prosaposin A (PSAP), a glycoprotein, is differentially expressed in the saliva of patients with squamous cell carcinoma of the head and neck region (HNSCC). The present study was planned to analyse the level of PSAP in serum and saliva of HNSCC patients and compare the same with levels in other squamous cell cancer patients and healthy controls.
Methods
Biopsy proven HNSCC patients (n=30), previously untreated, were recruited for the study along with 30 patients of squamous cell carcinoma of cervix and 30 age and sex matched healthy controls following specific inclusion/ exclusion criteria. Serum and saliva samples were collected on the day of recruitment. The patients were treated according to departmental protocol and post treatment samples were collected after 6 weeks of completion of treatment. An ELISA assay was run to measure the PSAP levels. The pre- and post treatment values were compared. Wilcoxon matched-pairs signed rank test was used for statistical analysis. The difference in levels of PSAP in patients and healthy controls were tested for significance using Mann Whitney test.
Results
Serum PSAP levels were significantly elevated at baseline when compared between patients and healthy controls (p=0.0123). Comparing the pre- and post treatment levels of PSAP in patients, the levels decreased significantly after appropriate treatment (p< 0.0001). However, the levels of PSAP in saliva was not significantly different between patients and healthy volunteers. The expression of serum PSAP was not significantly different between head neck and cervical cancer patients.
Conclusion
Serum PSAP levels were significantly elevated when compared to healthy individuals and this level reduced significantly after appropriate therapy. There is a scope of using PSAP as a biomarker for HNSCC patients in future. ABT0036: Fusobacterium nucleatum nus G Gene Expression in Head and Neck Cancers and Its Correlation with Clinicopathological Features Gourav Popli, Sumedha Mohan1, U. S. Pal1, V. Vimla2, Piyush Tripathi3, Anuj Verma4 Karkinos Healthcare Pvt Ltd, Departments of 1OMFS and 2Microbiology, KGMU, 3KGMU, Lucknow, Uttar Pradesh, India, 4University of Alabama, Tuscaloosa, AL, USA E-mail: [email protected] Objectives: a) To examine the presence of Fusobacterium Nucleatum (biopsy specimen). b) To find the relationship between Fusobacterium Nucleatum DNA status and the clinicopathologic features. Methodology: Total 100 Patients suffering from Head and Neck Cancer who underwent biopsy were examined in the study with adjacent normal tissue as control. Demographics and clinicopathologic data was collected. Quantification of Fusobacterium nucleatum DNA was done and compared by qPCR. Genomic DNA was extracted from FFPE cancer tissues and amount of F. nucleatum DNA was determined by qPCR assay. The nus G gene of F. nucleatum and the reference human gene SLCO2Al was amplified using custom-made TaqMan primer/ probe sets. The amount of F. nucleatum DNA in each tissue was normalized relative to SLCO2A1. Relationship between F. Nucleatum positivity was associated with Demographical (sex and age) and clinicopathological data (differentiation status, tumor size, locoregional lymph node status and distant metastasis).
Results
The mean fold change of the nus G gene in biopsy samples was 64.127 (SD = 182.2) and in adjacent normal tissue was 1.026 (SD= 0.08592). The median fold change of nus G gene in biopsy samples was 4.405 (IQR=0.942-41.05) and in adjacent normal tissue was 1.003 (IQR=l-1.0175). Analysis of median normalized expression of F. nucleatum nus G gene (normalized to SLCO2Al) is statistically significant (Mann-Whitney U test): Z= -5.82, p= < 0.001, suggesting F. nucleatum nus G gene is overrepresented in biopsy specimens compared to adjacent normal tissue. Secondarily, the expression of the nus G gene of F. nucleatum was higher in cancer tissue compared with adjacent normal tissue in 74 of 100 samples. Positivity of F. nucleatum nus G gene expression was not associated with N stage (r=-0.003; p=0.979). It was associated with T stage (r=0.401; p < 0.001).
Discussion
A highly significant overrepresentation of F. nucleatum in tumor samples was observed compared with adjacent normal tissues. Our finding is consistent with the work of Bronzato et al. 2020, a meta-analysis (13 studies) detecting F. nucleatum being 2.93-fold more likely to be present in head and neck cancer tissues compared with normal. Secondarily, the relative abundance of the F. nucleatum nus G gene increased significantly with respect to clinical T stage, i.e., tumor size, and its positivity was not associated with lymph node metastasis. It is consistent with the findings of Li et al. 2021, observed that frequency of F. nucleatum was closely related to the T stage of esophageal cancer, but not to lymph node metastasis. Chi-Yao et al. 2022 observed higher Fusobacterium abundance leads to a worse prognosis for patients with head and neck cancer.
Conclusion
Our work provides insights into relationship between clinicopathologic features and F. nucleatum, as literature on this topic is far from sufficient especially regarding molecular mechanisms. Long-term follow-up studies are needed to tell whether it is a prognostic and diagnostic marker. ABT0051: Community Based Oral Cancer Risk Assessment Using Smartphone Application in West Bengal: A Report of Preliminary Findings Manish Tiwari, Akhter Jawade, Indrajeet Kumar, Jyotirup Goswami, Moni Kuriakose Karkinos Healthcare E-mail: [email protected]
Introduction
India witnesses a high incidence and mortality rate associated with oral cancer, making it a pressing public health concern. The gravity of the situation calls for innovative approaches to screen and detect high-risk cases of early oral cancers and potentially malignant disorders (OPMD). In the present paper we have reported initial findings of an innovative approach of physital model that combines smartphone-based technology with community-based outreach and awareness activities for assessing risk of oral cancer in general population.
Aim
Population based oral cancer risk stratification of rural and semi urban regions of West Bengal using smart phone application.
Objectives
Primary objective: To evaluate percentage of individuals with high risk for oral cancers in West Bengal, Secondary objectives: (1) To investigate risk factors for oral cancer in different geographies of West Bengal. (2) To evaluate demographics of individuals at high risk of oral cancer. (3) To identify most common high-risk symptoms in given population. Methodology: Between 1st to risk for common cancers was in in West Bengal for with age 30 and To in given a was with and the were and for using smartphone-based risk application. The data of with elevated risk of oral cancers were using statistical Results: A of individuals smart of elevated risk for different cancers of elevated risk for oral were The most common was by of high-risk individuals the most common age was between by The most common was in by more in neck Discussion: was the most of elevated oral risk elevated risk to to an a approach to elevated risk the of Conclusion: it was that was the for elevated risk of oral cancer and There is an to early cancers and to and awareness the on associated health in Head and Neck Cancer Patients in the Population of from to Pvt E-mail: [email protected]
Aim
The present study was to study treatment and of head and neck cancer in the of Objectives: To evaluate rate and of Methodology: have a study of patients with Head and Neck Cancer in in from to Patients with Results: with a Discussion: Head and Neck cancer is the most common cancer and for cases in as the and oral and and and are risk factors for in An increased incidence of to in The of is with the being observed in as is in more Oral cancer is the most common in study and the of and were to be in cell carcinoma is the most common cancer with of the cancer most being of the were with and with were cancer, and cancer, the were in patients in stage and on to have data in cancer in the and the cancer The study that the incidence of Head and Neck cancers is significantly high in being cell a for early and of this There is a to awareness the of and for of the of head and neck and risk of head and neck cancers in Head Neck in Head and Neck Cancer India E-mail: [email protected]
Aim
A of patients, as head and neck squamous cell carcinoma at Objectives: To evaluate rate with To evaluate of To evaluate Methodology: of study HNSCC Patients who at from 2022 to Results: The following were Discussion: patients treated for have a to and patients distant metastasis. the in and of HNSCC patients who the as as factors as based with of for patients with as 6 of based Oral in However, given the of of the patients are to it as that to the by and The of to and have for patients with and and we to present a of cases of patients suffering from head and neck cancers and rate post The of on head and neck squamous cell A Oral et al. for and head and neck cancers and factors it in a in et al. squamous cell carcinoma of the head and A and be by locoregional and Cancers et al. and of in head and neck squamous cell after follow-up in Cancer with for Analysis to Study and to Institute of Medical India E-mail: [email protected] Objectives: are in the for is used in clinical and The of this study was to based and to study and in public related Methodology: were and and related to by the patients and were An was used for topic based on and The extracted as with were used to identify and the and A was done to the as The study was done in (1) related (2) related Results: were from public a of the of In the were The of the patients were related and A in in and in The most were from the to the and related In were The of were symptoms and The were health and symptoms A in in and in Discussion: and is using of and reported have studies are the other and The of is the study that to the and related to and were used to the to The related are the most in the In the were the most concern. The in the sets. study be used for into the in Podium/Poster Presentation of in the of V. Medical India E-mail: [email protected] is the for into based on The for the is being used in to of and the in paper to compare the of with respect to and change in Methods: The patients collected data of patients with was compared with a of patients who of in of on change in treatment and were and were done to the factors that of A p < be statistically Results: The mean age of study was and were the underwent The of was was in of and of of by and the of detecting by compared to There was a in the of in by by presence of p= p= in a on of Conclusion: The of is high in population. not in but it of It to the of of of in be in the of Patients with Oral S. of Head and Neck India E-mail: [email protected] Introduction: cell carcinoma of the oral is the most cancer of the head and neck A is needed to identify who have a high risk of the percentage of patients with cancer between and when at an early stage, DNA from saliva a biomarker that the of the diagnostic Aim: To a test that early of oral squamous cell Objectives: (1) of this study was to a test for (2) to (3) To high for early Methodology: of In to the of in we a with molecular used this on DNA from and matched saliva and Discussion: were in using is in with an rate of of saliva samples to A of this approach was to that are not to saliva samples of saliva samples from healthy a of and using a of it was that the is and to Conclusion: The that saliva samples at the of be used to identify in of Head and Neck Cancer Departments of and India E-mail: [email protected] and Objectives: To study the of Head and Neck To compare the presence of DNA in different of Head and Neck Methodology: A study was a of tissue from biopsy samples was and A in test for of DNA and of high risk of was was done by test and T test using Results: of the patients in the patients oral and 6 patients by and who patients each of the patients with Oral status of the 6 was other were to be of HNSCC cases in study were of by In study the HNSCC patients were for that the samples were for and but for risk and Discussion: The of HNSCC in the present study was studies have that studies on related from to the The of was the percentage of was significant p were to the other done in the cases of HNSCC were to to other high risk in to other studies the of the cancers were for by and other high-risk Conclusion: is associated with HNSCC associated cancer in other is to be more in Our study that is more associated with HNSCC as compared to other to other studies done in It is to the change in of molecular and treatment with in associated studies the and treatment with respect to of HNSCC be the of in of Head and Neck Cancers and its India E-mail: [email protected]
Aim
To the of factors on the of in head and neck the of biopsy and and To evaluate the diagnostic and of in Methodology: study from 2022 to Results: The diagnostic the following and The diagnostic after the biopsy was increased to after the was observed in of and were factors as treatment post and Analysis that of factors were statistically significant However, the model as a was significant that treatment and significantly the diagnostic The for was for patients, with other factors and significant and in of patients, of patients was Conclusion: present a to a and for early of in Patients of Head Neck Cancers of Head and Neck and Institute of Medical India E-mail: [email protected]
Objectives
The of this study is to the diagnostic of and to compare it to that of clinical in head neck cancer patients. Methodology: is a a of of head neck cancers patients with was The patients initial treatment at Institute of Medical between and Clinical diagnostic were done to the patients as for the patients underwent Patients were as and for most of the patients underwent biopsy to the presence of biopsy was clinical was to the presence of The for positivity was as a measure of positivity and were as of diagnostic Results: for was for in patients with in in in It was done as a in The was most used for oral in in most for by were clinical was present in patients was in was as a mean of clinical of was in patients Clinical the of the values for were of Discussion: of and into diagnostic reported as highly for is a data from India clinical to the of in the of head and neck not to in the and of head and neck The present study significant in diagnostic with compared with clinical of and of values with are for with of and S. Cancer E-mail: [email protected] of the To a for with of and using of the (1) features from of HNSCC (2) features with expression and on (3) a model for to treatment. Methodology: The study is a data from and of patients with expression and and studies for A and the of and features from is being Results: Primary (1) of (2) of expression on the (3) and of the Secondary of The statistical to and Correlation examine between features and be to a Discussion: Head and neck squamous cell carcinoma are a with prognostic and The significantly and to treatment. are associated with locoregional in squamous cell carcinoma patients as in with are used for more of patients distant the molecular and of HNSCC associated with and for the patients. of features to the of a for the The findings of the and in treatment for A expression and and insights into the between and in Report of an in the A Cancer and India E-mail: [email protected] Introduction: is an in the of the oral is it is by with and is was the to the of with and this tumor is as an of the of in a of with of the to the and of the in the region of and for in on was in not on biopsy from the of and on reported as with a to the with of was and biopsy not and of the was done with were for of The was given an with protocol based on and by is There of and after of in the Clinical and of in the (1) The of the tumor is an (2) of (3) of in analysis. The of the are of in to the cell Discussion: It is an with a and is associated with to the of is risk study for of an approach tissue samples for of and assay. in A for to the in cases by with and as of the therapy. is a with a to its to in the oral biopsy of the in the be done to in the future. of in Oral A Cancer India E-mail: [email protected]
Aim
To a for the of this To and awareness of the of in oral Methodology: of literature and the of in of the oral used and oral cancer for on Discussion: have that the for and for oral cancer are of initial and are et cancer of the risk factors of an to and to is the of the to the of the especially in of cancer. tissue adjacent to the tumor to the of in tumor of and a for the In a study by et of from healthy and that of and of samples of It that a in the of the from and the cancer after to on the same studies have and on samples from a stage from tumor lymph node and biopsy after and a in the same as in the biopsy and are by the In the clinical is of a by of in the adjacent that the of tumor tissue. In a the were with molecular of and and the was compared with that of the have the as cancer of and the and with diagnostic biopsy and follow-up Conclusion: biomarker and on the of that the of the of the be in risk early and To identify the patients who are to this studies and with this and prognosis by Presentation of for Cancer and Pradesh, India E-mail: [email protected] for Cancer and Pradesh, India E-mail: [email protected] of E-mail: [email protected] Medical Podium/Poster Presentation Assessment of in Head and Neck Cancer Institute of India E-mail: [email protected] and used in patients with head and neck cancers with the of and in rate of distant The of this study was to post in patients with and factors this and to Methodology: was a study at a cancer patients with with in between 2022 to were in the Patients and based on of the The was done using factors for as of and stage, for of and of were using test and Results: A of patients were for analysis. common was oral by common for were and node of the patients the was in in in and in the factors to age and of significant on analysis. was significantly higher when of was for and tissue on of were patients were treatment post in the of patients patients patients were treatment as in Discussion: of in is by studies et et The to is to factors are in Our study reported an rate of of with not higher N stage, tissue on on significance of Conclusion: study that in patients an The with of of was Head and neck of Podium/Poster A Study to the India E-mail: [email protected] a common of in of the In this we have to evaluate the of neck following patients Methods: In this we have the of patients and following using the and Assessment and the Assessment Results: A of patients who underwent = for = were The median from was The median age of the patients was and the were = The median was the median for was for was and for the it was suggesting the and the patients. The between the was but between the and patients The in the was with the patients and the to be with following patients, in Oral Cancer A in Cancer India E-mail: [email protected]
Objectives
(1) To study the incidence and the of head and neck in patients treatment for oral cancer. (2) To study the of on and and after 6 of treatment. and Methods: The study was a of patients treatment for oral cancer were in the the study were from the and treatment were Head and Neck for for for and for were the Patients were into (1) Patients with (2) Patients with Results: patients were in the patients underwent with therapy. T
Zitieren
APA
(2024). Abstracts - 23rd FHNO Conference, 2023. Journal of Head & Neck Physicians and Surgeons. https://doi.org/10.4103/2347-8128.243190
Vancouver
Abstracts - 23rd FHNO Conference, 2023. Journal of Head & Neck Physicians and Surgeons. 2024. doi:10.4103/2347-8128.243190
BibTeX
@article{euvimed2024,
title = {Abstracts - 23rd FHNO Conference, 2023},
journal = {Journal of Head & Neck Physicians and Surgeons},
year = {2024},
doi = {10.4103/2347-8128.243190}
}
EUVIMED